Loading...
Loading...
Below are the top drug manufacturers-other stocks on the NASDAQ in terms of EPS growth forecast for the next five years.
Cumberland Pharmaceuticals, Inc.CPIX earnings per share growth forecast for the next five years is 30.00 percent. Cumberland Pharmaceuticals' trailing-twelve-month revenue is $37.50 million.
Depomed Inc DEPO EPS growth forecast for the next five years is 30.00 percent. Depomed's trailing-twelve-month operating margin is 55.30 percent.
POZEN Inc. POZN EPS growth forecast for the next five years is 30.00 percent. POZEN's PEG ratio is 0.49.
CARDIOME PHARMA CORP CRME earnings per share growth forecast for the next five years is 28.00 percent. CARDIOME PHARMA's trailing-twelve-month gross margin is 64.90 percent.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in